Search results
Results from the WOW.Com Content Network
However, it is acceptable to screen this age group with a Pap smear alone every 3 years or with an FDA-approved primary high risk HPV test every 5 years. [11] In women over the age of 65, screening for cervical cancer may be discontinued in the absence of abnormal screening results within the prior 10 years and no history of high-grade lesions ...
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
The pelvic exam begins with a discussion as described above, and an explanation of the procedure. The patient is asked to put on an examination gown, get on the examination table, and lie on her back with her feet in footrests. [3] Sliding down toward the end of the table is the best position for the clinician to do a visual examination. [18]
According to Dr. Harrison, “Women should stop having cervical cancer screening after age 65 if they do not have a history of abnormal cervical cells or cervical cancer, and they have had either ...
Depending on patient's age or Pap smear result, HPV testing may also be performed. Sexually transmitted infection screening - Depending on age and risk factors, clinicians may recommend gonorrhea or chlamydia testing at the time of the well-woman exam. This sample can be collected via a swab of the cervix or vagina.
Micrograph showing navicular cell in extremely high magnification. Navicular cell is a boat-shaped benign epithelial cell seen in Pap smear. [1] They are seen in pregnancy (most prominently during smears taken in the second trimester), [2] second half of menstrual cycle, during menopause and in women using medroxyprogesterone acetate (depo-provera) for contraception.
Because of the link between HPV and cervical cancer, the ACS currently recommends early detection of cervical cancer in average-risk asymptomatic adults primarily with cervical cytology by Pap smear, regardless of HPV vaccination status. Women aged 30–65 should preferably be tested every 5 years with both the HPV test and the Pap test.
For example, a common application of cytopathology is the Pap smear, a screening tool used to detect precancerous cervical lesions that may lead to cervical cancer. Cytopathologic tests are sometimes called smear tests because the samples may be smeared across a glass microscope slide [ 4 ] for subsequent staining and microscopic examination.